Dafna Capital Management LLC Hookipa Pharma Inc. Transaction History

Dafna Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.26 - $2.52 $403,759 - $807,518	-320,444 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.33 - $5.94 $3,914 - $9,979	-1,680 Reduced 0.52%	320,444 $747,000
Q2 2021 Aug 16, 2021	SELL	$9.16 - $19.51 $195,391 - $416,167	-21,331 Reduced 6.21%	322,124 $2.95 Million
Q1 2021 May 17, 2021	BUY	$10.64 - $14.7 $994,361 - $1.37 Million	93,455 Added 37.38%	343,455 $4.62 Million
Q4 2020 Feb 16, 2021	BUY	$9.32 - $13.63 $2.12 Million - $3.11 Million	227,939 Added 1033.22%	250,000 $2.77 Million
Q3 2020 Nov 16, 2020	SELL	$8.59 - $11.89 $498,709 - $690,297	-58,057 Reduced 72.46%	22,061 $209,000
Q2 2020 Aug 14, 2020	BUY	$7.23 - $12.1 $579,253 - $969,427	80,118 New	80,118 $931,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $139M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.